Dianthus Therapeutics (DNTH) Stock
Dianthus Therapeutics (DNTH) closed at $91.81 on Nov 13, 2026; its Tenet Score is 64 of 100 against 409 Healthcare peers.
26 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $91.81
- Nov 13, 2026
- Market cap
- $5.2B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 34.29 – 117.88
- low → high
- Tenet Score
- 64/100
- Solid · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Dianthus Therapeutics Inc scores 64/100. Solid. Strongest on financial health versus 409 Healthcare peers. Insufficient inputs: Tenet 64 is built from 3 of 4 pillars, from 45% of its inputs. Growth is left out because no growth rate could be measured.
Tenet Score · vs sector
n=409Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ~ Drawdown Context
- ✕ Reversal Evidence
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibo…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| ImmunityBio IncIBRX | 53 | $6.4B |
| Ligand Pharmaceuticals, Inc.LGND | 46 | $6.2B |
| Grifols SAGRFS | 50 | $6.0B |
| PTC Therapeutics IncPTCT | 74 | $5.3B |
| Liquidia CorpLQDA | 46 | $5.1B |
| Edgewise Therapeutics IncEWTX | 68 | $5.0B |
| Cogent Biosciences IncCOGT | 33 | $5.0B |
| Travere Therapeutics IncTVTX | 43 | $4.9B |
| Ionis Pharmaceuticals IncIONS | 29 | $4.8B |
| Definium Therapeutics Inc.DFTX | 50 | $4.4B |
Common questions
What sector and industry is Dianthus Therapeutics in?
Dianthus Therapeutics is in the Healthcare sector and the Drugs industry.
What is Dianthus Therapeutics' Tenet Score?
Dianthus Therapeutics' Tenet Score is 64 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




